XRCC1基因Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系

目的探讨X射线损伤交叉互补蛋白1(XRCC1)Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系。方法选择接受铂类药物化疗的胃癌患者80例,采用聚合酶链式反应-连接酶检测反应技术检测XRCC1基因Arg194Trp位点基因型。所有患者术后接受以奥沙利铂为主的一线化疗方案,根据化疗效果分为化疗敏感者和化疗耐药者,分析XRCC1基因Arg194Trp位点多态性与化疗敏感性的关系。结果 XRCC1基因Arg194Trp位点存在Arg/Arg、Arg/Trp、Trp/Trp三种基因型,分布频率分别为42.5%(34/80)、50.0%(40/80)、7.5%(6/80);三种基因型分布满足Ha...

Full description

Saved in:
Bibliographic Details
Published in山东医药 Vol. 57; no. 8; pp. 5 - 8
Main Author 钟兰 黄涛 谢贤和 符生苗 高允锁 吴华 钟佩君
Format Magazine Article
LanguageChinese
Published 海南省人民医院,海口,570311%福建医科大学附属第一医院 2017
Subjects
Online AccessGet full text
ISSN1002-266X
DOI10.3969/j.issn.1002-266X.2017.08.002

Cover

Abstract 目的探讨X射线损伤交叉互补蛋白1(XRCC1)Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系。方法选择接受铂类药物化疗的胃癌患者80例,采用聚合酶链式反应-连接酶检测反应技术检测XRCC1基因Arg194Trp位点基因型。所有患者术后接受以奥沙利铂为主的一线化疗方案,根据化疗效果分为化疗敏感者和化疗耐药者,分析XRCC1基因Arg194Trp位点多态性与化疗敏感性的关系。结果 XRCC1基因Arg194Trp位点存在Arg/Arg、Arg/Trp、Trp/Trp三种基因型,分布频率分别为42.5%(34/80)、50.0%(40/80)、7.5%(6/80);三种基因型分布满足HardyWeiberg基因遗传平衡定律,具有群体代表性。Arg/Arg、Arg/Trp、Trp/Trp基因型患者性别、年龄、组织类型、TNM分期、化疗方案等临床病理参数比较差异均无统计学意义(P均〉0.05)。80例患者中,化疗敏感(完全缓解+部分缓解)39例(48.8%),耐药(稳定+进展)41例(51.2%);Arg/Trp、Trp/Trp基因型者化疗敏感率均显著高于Arg/Arg者(P均〈0.05),Arg/Trp与Trp/Trp基因型患者化疗敏感率比较差异无统计学意义(P〉0.05)。结论 XRCC1基因Arg194Trp位点多态性与胃癌患者铂类药物化疗敏感性有关;检测Arg194Trp位点多态性可为胃癌化疗的个体化用药提供依据。
AbstractList 目的探讨X射线损伤交叉互补蛋白1(XRCC1)Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系。方法选择接受铂类药物化疗的胃癌患者80例,采用聚合酶链式反应-连接酶检测反应技术检测XRCC1基因Arg194Trp位点基因型。所有患者术后接受以奥沙利铂为主的一线化疗方案,根据化疗效果分为化疗敏感者和化疗耐药者,分析XRCC1基因Arg194Trp位点多态性与化疗敏感性的关系。结果 XRCC1基因Arg194Trp位点存在Arg/Arg、Arg/Trp、Trp/Trp三种基因型,分布频率分别为42.5%(34/80)、50.0%(40/80)、7.5%(6/80);三种基因型分布满足HardyWeiberg基因遗传平衡定律,具有群体代表性。Arg/Arg、Arg/Trp、Trp/Trp基因型患者性别、年龄、组织类型、TNM分期、化疗方案等临床病理参数比较差异均无统计学意义(P均〉0.05)。80例患者中,化疗敏感(完全缓解+部分缓解)39例(48.8%),耐药(稳定+进展)41例(51.2%);Arg/Trp、Trp/Trp基因型者化疗敏感率均显著高于Arg/Arg者(P均〈0.05),Arg/Trp与Trp/Trp基因型患者化疗敏感率比较差异无统计学意义(P〉0.05)。结论 XRCC1基因Arg194Trp位点多态性与胃癌患者铂类药物化疗敏感性有关;检测Arg194Trp位点多态性可为胃癌化疗的个体化用药提供依据。
R735.2; 目的 探讨X射线损伤交叉互补蛋白1(XRCC1)Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系.方法 选择接受铂类药物化疗的胃癌患者80例,采用聚合酶链式反应-连接酶检测反应技术检测XRCC1基因Arg194Trp位点基因型.所有患者术后接受以奥沙利铂为主的一线化疗方案,根据化疗效果分为化疗敏感者和化疗耐药者,分析XRCC1基因Arg194Trp位点多态性与化疗敏感性的关系.结果 XRCC1基因Arg194Trp位点存在Arg/Arg、Arg/Trp、Trp/Trp三种基因型,分布频率分别为42.5%(34/80)、50.0%(40/80)、7.5%(6/80);三种基因型分布满足Hardy-Weiberg基因遗传平衡定律,具有群体代表性.Arg/Arg、Arg/Trp、Trp/Trp基因型患者性别、年龄、组织类型、TNM分期、化疗方案等临床病理参数比较差异均无统计学意义(P均>0.05).80例患者中,化疗敏感(完全缓解+部分缓解)39例(48.8%),耐药(稳定+进展)41例(51.2%);Arg/Trp、Trp/Trp基因型者化疗敏感率均显著高于Arg/Arg者(P均<0.05),Arg/Trp与Trp/Trp基因型患者化疗敏感率比较差异无统计学意义(P>0.05).结论 XRCC1基因Arg194Trp位点多态性与胃癌患者铂类药物化疗敏感性有关;检测Arg194Trp位点多态性可为胃癌化疗的个体化用药提供依据.
Abstract_FL Objective To explore the correlation between X-ray cross complementing repair gene 1 (XRCC1) gene Arg194Trp polymorphism and platinum-based chemotherapy in patients with gastric cancer.Methods Eighty patients with gastric cancer who underwent platinum-based chemotherapy were selected,and the XRCC1 genotypes were detected by multiplex PCR and ligase detection reaction (LDR).All patients were treated with oxaliplatin-based first-line chemotherapy.Accorded to the curative effect standard of gastric cancer treatment,the patients were divided into the platinum sensitive group and platinum resistance group,and the correlation between XRCC1 gene Arg194Trp polymorphism and platinumbased chemotherapy was analyzed.Results There were three kinds of genotypes in XRCC1 gene Arg194Trp:Arg/Arg,Arg/Trp,and Trp/Trp,their distribution frequencies were 42.5% (34/80),50% (40/80),and 7.5% (6/80),respectively.The proportional distribution of the three genotypes met genetic equilibrium law of Hardy-Weiberg,and the experimental subjects were representative.There were no significant differences in sex,age,histological type,TNM stage,chemotherapy regimen in patients with Arg/Arg,Arg/Trp,and Trp/Trp genetypes (all P > 0.05).In 80 patients,platinum drug sensitivity (CR + PR) was found in 39 patients (48.8%),and platinum drug resistance (SD + PD) in 41 patients (51.2%).The sensitivity of platinum drugs in patients with Arg/Trp and Trp/Trp genotypes was significantly higher than that in patients with Arg/Arg genotype (P < 0.05),and there was no significant difference between Arg/Trp and Trp/Trp genotypes in patients (P >0.05).Conclusion The XRCC1 gene Arg194Trp is related with the sensitivity of platinum-based drugs in patients with gastric cancer,and the detection of Arg194Trp polymorphism can provide a basis for individual chemotherapy of gastric cancer.
Author 钟兰 黄涛 谢贤和 符生苗 高允锁 吴华 钟佩君
AuthorAffiliation 海南省人民医院,海口570311 福建医科大学附属第一医院
AuthorAffiliation_xml – name: 海南省人民医院,海口,570311%福建医科大学附属第一医院
Author_FL GAO Yunsuo
ZHONG Lan
FU Shengmiao
WU Hua
HUANG Tao
ZHONG Peijun
XIE Xianhe
Author_FL_xml – sequence: 1
  fullname: ZHONG Lan
– sequence: 2
  fullname: HUANG Tao
– sequence: 3
  fullname: XIE Xianhe
– sequence: 4
  fullname: FU Shengmiao
– sequence: 5
  fullname: GAO Yunsuo
– sequence: 6
  fullname: WU Hua
– sequence: 7
  fullname: ZHONG Peijun
Author_xml – sequence: 1
  fullname: 钟兰 黄涛 谢贤和 符生苗 高允锁 吴华 钟佩君
BookMark eNo9j01LAkEcxudgkFpfIjp0cZuX3Zndoyy9gVCEB28yO45v1Gi7RHgztUOgdYiM7GCHIDpFeKmkb-Pu2rdowuj0f3j48Tz_JwUSqqEkAOsIGsShzmbdqAWBMhCEOIMpLRgYImZA29BGAiT__WWQCoI6hCZGzEmCg8Kh66Jw_Bk-PGb9CnLMvN-cfQ3izkf4NIra51H7efZ-Ne924_v-900nfpvOB6_x5UvYH8bDu-j2OuqNNROPeuHFJJ5MV8BSmR8FcvXvpkF-eyvv7mZy-zt7bjaXEVR_ImwIic0EY5Byy3NY2eSmZXEkEKeexAR5pCSkR6C0kVeS2LSkYEJYklKkJUmDjUXsGVdlrirFeuPUV7qwGFS5KrVav_OhbsEaXVugotpQlZOahpt-7Zj7rSJliFqEYUx-AJJndpE
ClassificationCodes R735.2
ContentType Magazine Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1002-266X.2017.08.002
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Correlation between XRCC1 gene Arg194Trp polymorphism and platinum-based chemotherapy in patients with gastric cancer
DocumentTitle_FL Correlation between XRCC1 gene Arg194Trp polymorphism and platinum-based chemotherapy in patients with gastric cancer
EndPage 8
ExternalDocumentID shandyy201708002
671653722
GrantInformation_xml – fundername: 海南省医学科研立项课题
  funderid: (琼卫[2012]PT-17)
GroupedDBID -05
2B.
2C~
2RA
5XA
5XF
92F
92I
92L
ABDBF
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
CW9
EOJEC
OBODZ
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ABJNI
ACUHS
PSX
ID FETCH-LOGICAL-c602-c800387c7706a5b97f4a455a1c1a6be231b3dceb30e81bde245ec7cc5e6615ec3
ISSN 1002-266X
IngestDate Thu May 29 04:06:27 EDT 2025
Wed Feb 14 10:03:26 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 8
Keywords single nucleotide polymorphism
单核苷酸多态性
platinum resistance
X-ray cross complementing repair gene 1
胃癌
铂类耐药
gastric carcinoma
X射线损伤交叉互补蛋白1
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c602-c800387c7706a5b97f4a455a1c1a6be231b3dceb30e81bde245ec7cc5e6615ec3
Notes 37-1156/R
ZHONG Lan, HUANG Tao, XIE Xianhe, FU Shengmiao, GAO Yunsuo WU Hua, ZHONG Peijun ( 1 Hainan General Hospital, Haikou 570311, China)
gastric carcinoma; X-ray cross complementing repair gene 1; single nucleotide polymorphism;platinum resistance
Objective To explore the correlation between X-ray cross complementing repair gene 1 (XRCC1) gene Arg194Trp polymorphism and platinum-based chemotherapy in patients with gastric cancer. Methods Eighty patients with gastric cancer who underwent platinum-based chemotherapy were selected, and the XRCC1 genotypes were detected by mul- tiplex PCR and ligase detection reaction (LDR). All patients were treated with oxaliplatin-based first-line chemotherapy. Accorded to the curative effect standard of gastric cancer treatment, the patients were divided into the platinum sensitive group and platinum resistance group, and the correlation between XRCC1 gene Arg194Trp polymorphism and platinum- based chemotherapy was analyzed. Results There were three kinds of genotypes in XRC
PageCount 4
ParticipantIDs wanfang_journals_shandyy201708002
chongqing_primary_671653722
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 山东医药
PublicationTitleAlternate Shandong Medical Journal
PublicationTitle_FL Shandong Medical Journal
PublicationYear 2017
Publisher 海南省人民医院,海口,570311%福建医科大学附属第一医院
Publisher_xml – name: 海南省人民医院,海口,570311%福建医科大学附属第一医院
SSID ssj0042179
ssib001104105
ssib017477535
ssib051371736
ssib002262813
Score 1.3331239
Snippet 目的探讨X射线损伤交叉互补蛋白1(XRCC1)Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系。方法选择接受铂类药物化疗的胃癌患者80例,采用聚合酶链式反应-连接酶检测反...
R735.2; 目的 探讨X射线损伤交叉互补蛋白1(XRCC1)Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系.方法 选择接受铂类药物化疗的胃癌患者80例,采用聚合酶链式反应-连接...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 5
SubjectTerms X射线损伤交叉互补蛋白1
单核苷酸多态性
胃癌
铂类耐药
Title XRCC1基因Arg194Trp位点多态性与胃癌铂类药物化疗敏感性的关系
URI http://lib.cqvip.com/qk/92062X/201708/671653722.html
https://d.wanfangdata.com.cn/periodical/shandyy201708002
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1BT9RAFJ4gJMaTGjUiajBhTpuFbTvtzBw7u90QD8aYNeG2mQ5dOC24wAFOCHgwAT0YMeIBDybGkzFcVOK_Ybf4L3xvWro9EKImm8lk-ua91_c6fd9rX2cJmdLzNT8WWlQ14NUqMx1ZlS43Vd6BVc49BO12t89HwexT9nDOnxu5NFOqWlpbjafNxrnflfyPV2EM_Ipfyf6DZwumMAB98C-04GFo_8rHc0_qdYdGPpVNqkLbUTSshb0FR7JWb5lGjKoGFQ0acSpcqiTShIxKIA6wyEE4eSfkllhQEdEIWg9_MEtKKuo0klR6yAFGlEOVsjQNGjYtZ0lDyxkoZWBnBVRy5CxhsGlFMFRyKIujDjCIs3yqrCxolSqjZTyK4pxcN1nPpZQUOLtirI6uFZKxrFVwCChRSkAVKKMqOE2BBq7tMLQFWs0FphVUIazTMDuDTF8QouBULKsQeiLnjnaTSCSciuVQQ254DMwdVUrKWA9k5gEiqcqPWRxeesySRQYMHW72t4tF6Mj21s6XiCjFAb8MKM6LVJ4MpI1UyHy6YI61hnw6q-8dRuiibjKA7Nb3uAuYY8zlABZHyVioGqo5RMCQXjulWziga1cMERvknxwS1OK473hYhhGcgRcGGaq0BQK5QpfJVK7tzEW64s4ki0vdhWeAt-znb92O7i6UkFrrGrl6tmX6ZJgtmOtkZGPxBnlsF0v_8Gf_w8digZz82ku3fvQ_HQw2nw82P598f3W6vZ2-3_39Ziv9dny69zV9-aW_u5_uvxu8fT3YOQSa9GCn_-IoPTq-SVrNqFWfreZ_J1I1AahsBL4F54bzWqD9WPIO08z3tWMcHcQJ5DmxN2-S2KslkMrNJy7zE8ON8ROAsND1bpHR7lI3uU0mHaaNMa6OTdBhgaOlG2st4g7A54Rro8fJRGGN9nK2a0y78N04eZDbp53fS1baK_iabH0dLWpTuDsXcpggV4aX6F0yutpbS-4BNl6N7-fXwx_4VI8Q
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=XRCC1%E5%9F%BA%E5%9B%A0Arg194Trp%E4%BD%8D%E7%82%B9%E5%A4%9A%E6%80%81%E6%80%A7%E4%B8%8E%E8%83%83%E7%99%8C%E9%93%82%E7%B1%BB%E8%8D%AF%E7%89%A9%E5%8C%96%E7%96%97%E6%95%8F%E6%84%9F%E6%80%A7%E7%9A%84%E5%85%B3%E7%B3%BB&rft.jtitle=%E5%B1%B1%E4%B8%9C%E5%8C%BB%E8%8D%AF&rft.au=%E9%92%9F%E5%85%B0+%E9%BB%84%E6%B6%9B+%E8%B0%A2%E8%B4%A4%E5%92%8C+%E7%AC%A6%E7%94%9F%E8%8B%97+%E9%AB%98%E5%85%81%E9%94%81+%E5%90%B4%E5%8D%8E+%E9%92%9F%E4%BD%A9%E5%90%9B&rft.date=2017-01-01&rft.issn=1002-266X&rft.volume=57&rft.issue=8&rft.spage=5&rft.epage=8&rft_id=info:doi/10.3969%2Fj.issn.1002-266X.2017.08.002&rft.externalDocID=671653722
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F92062X%2F92062X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fshandyy%2Fshandyy.jpg